Hilde Stevens

472 total citations
21 papers, 252 citations indexed

About

Hilde Stevens is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Hilde Stevens has authored 21 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 6 papers in Public Health, Environmental and Occupational Health and 4 papers in General Health Professions. Recurrent topics in Hilde Stevens's work include Pharmaceutical Economics and Policy (7 papers), Biomedical Ethics and Regulation (4 papers) and Intellectual Property and Patents (4 papers). Hilde Stevens is often cited by papers focused on Pharmaceutical Economics and Policy (7 papers), Biomedical Ethics and Regulation (4 papers) and Intellectual Property and Patents (4 papers). Hilde Stevens collaborates with scholars based in Belgium, Netherlands and United States. Hilde Stevens's co-authors include Isabelle Huys, Geertrui Van Overwalle, Bart Van Looy, Steven Simoens, Eline van Overbeeke, Rosanne Janssens, Henri Frédéricq, J. De Greef, Herman Steyaert and Mondher Toumi and has published in prestigious journals such as Nature Biotechnology, Nature Reviews Drug Discovery and PLANT PHYSIOLOGY.

In The Last Decade

Hilde Stevens

16 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hilde Stevens Belgium 9 102 49 36 33 28 21 252
Andrea Young United States 8 52 0.5× 16 0.3× 19 0.5× 19 0.6× 10 0.4× 21 258
Roberto Rodríguez‐Ibeas Spain 11 207 2.0× 23 0.5× 12 0.3× 6 0.2× 11 0.4× 29 309
Stuart Hogarth United Kingdom 12 54 0.5× 178 3.6× 27 0.8× 73 2.2× 118 4.2× 28 563
Maurice Cassier France 11 97 1.0× 63 1.3× 7 0.2× 17 0.5× 18 0.6× 49 332
Pallavi Mishra India 11 18 0.2× 21 0.4× 36 1.0× 69 2.1× 24 0.9× 59 371
Arthur Daemmrich United States 10 66 0.6× 34 0.7× 38 1.1× 31 0.9× 8 0.3× 32 297
Diego Rojas Chile 12 72 0.7× 56 1.1× 14 0.4× 127 3.8× 16 0.6× 55 427
Ida Ngueng Feze Canada 8 21 0.2× 56 1.1× 6 0.2× 26 0.8× 40 1.4× 12 205
Leah Marks Australia 8 15 0.1× 53 1.1× 8 0.2× 99 3.0× 14 0.5× 16 330
Rick J. Carlson United States 10 145 1.4× 50 1.0× 7 0.2× 22 0.7× 15 0.5× 21 360

Countries citing papers authored by Hilde Stevens

Since Specialization
Citations

This map shows the geographic impact of Hilde Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilde Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilde Stevens more than expected).

Fields of papers citing papers by Hilde Stevens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilde Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilde Stevens. The network helps show where Hilde Stevens may publish in the future.

Co-authorship network of co-authors of Hilde Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of Hilde Stevens. A scholar is included among the top collaborators of Hilde Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilde Stevens. Hilde Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Smedt, Delphine De, et al.. (2025). Societal participation in the development of orphan drugs: a systematic review. Frontiers in Medicine. 12. 1653304–1653304.
3.
Stevens, Hilde, et al.. (2025). Early access disparities in innovative therapies across the US, EU, China, and Japan. Frontiers in Medicine. 12. 1642882–1642882.
4.
Smedt, Delphine De, et al.. (2024). Cognition and communication in patients with spinal muscular atrophy: A systematic review. Heliyon. 10(13). e33677–e33677. 3 indexed citations
5.
Janssens, Rosanne, Kate Morgan, Margaux Verschueren, et al.. (2022). What matters most to patients with multiple myeloma? A Pan-European patient preference study. Frontiers in Oncology. 12. 1027353–1027353. 6 indexed citations
6.
Janssens, Rosanne, Kate Morgan, Maria-Elena Cabezudo, et al.. (2021). Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study. Frontiers in Medicine. 8. 686165–686165. 26 indexed citations
7.
8.
Overbeeke, Eline van, Mondher Toumi, Hilde Stevens, et al.. (2020). Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions. Drug Discovery Today. 26(2). 399–415. 29 indexed citations
9.
Stevens, Hilde, et al.. (2020). COVID-19, The Quarantine-Virus Disease. Frontiers for Young Minds. 8.
10.
Grine, Lynda, et al.. (2020). Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey. Frontiers in Medicine. 7. 36–36. 5 indexed citations
11.
Janssens, Rosanne, Isabelle Huys, Eline van Overbeeke, et al.. (2019). Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review. BMC Medical Informatics and Decision Making. 19(1). 189–189. 37 indexed citations
12.
Stevens, Hilde, et al.. (2019). From Opioid Pain Management to Opioid Crisis in the USA: How Can Public-Private Partnerships Help?. Frontiers in Medicine. 6. 106–106. 7 indexed citations
13.
Janssens, Rosanne, Eline van Overbeeke, Kim Pauwels, et al.. (2018). Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice. Frontiers in Medicine. 5. 285–285. 12 indexed citations
14.
Stevens, Hilde & Isabelle Huys. (2017). Innovative Approaches to Increase Access to Medicines in Developing Countries. Frontiers in Medicine. 4. 218–218. 39 indexed citations
15.
Stevens, Hilde, Geertrui Van Overwalle, Bart Van Looy, & Isabelle Huys. (2016). Intellectual property policies in early-phase research in public–private partnerships. Nature Biotechnology. 34(5). 504–510. 16 indexed citations
16.
Stevens, Hilde, Geertrui Van Overwalle, Bart Van Looy, & Isabelle Huys. (2015). Innovative Medicines Initiative (IMI) Case Study Analysis Reveals the True Added Value of Early-Phase Public-Private Partnerships (PPPs). Biotechnology Law Report. 34(4). 153–165. 4 indexed citations
17.
Stevens, Hilde. (2015). The Role of Intellectual Property in (Precompetitive) Public-Private Partnerships in the Biomedical Sector. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 1 indexed citations
18.
Stevens, Hilde, Geertrui Van Overwalle, Bart Van Looy, & Isabelle Huys. (2013). Perspectives and Opportunities for Precompetitive Public–Private Partnerships in the Biomedical Sector. Biotechnology Law Report. 32(3). 131–139. 21 indexed citations
19.
Frédéricq, Henri, et al.. (1987). Biphasic Fluence-Response Curves for Phytochrome-Mediated Kalanchoë Seed Germination. PLANT PHYSIOLOGY. 83(1). 126–130. 22 indexed citations
20.
Frédéricq, Henri, et al.. (1985). PROBIT ANALYSIS OF LOW AND VERY‐LOW FLUENCE‐RESPONSES OF PHYTOCHROME‐CONTROLLED Kalanchoe blossfeldiana SEED GERMINATION*. Photochemistry and Photobiology. 42(6). 697–703. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Young Breakdown of academic impact, for papers by Roberto Rodríguez‐Ibeas Breakdown of academic impact, for papers by Stuart Hogarth Breakdown of academic impact, for papers by Maurice Cassier Breakdown of academic impact, for papers by Pallavi Mishra Breakdown of academic impact, for papers by Arthur Daemmrich Breakdown of academic impact, for papers by Diego Rojas Breakdown of academic impact, for papers by Ida Ngueng Feze Breakdown of academic impact, for papers by Leah Marks Breakdown of academic impact, for papers by Rick J. Carlson
Rankless by CCL
2026